Terazosin Hydrochloride - Terazosin Hydrochloride
Navigation: NDC > Supplier starting with: C > CARDINAL HEALTH| Field | Value |
|---|---|
| NDC Code: | 55154-1375 |
| Proprietary Name: | Terazosin Hydrochloride |
| Suffix: | |
| Non-Proprietary Name: | Terazosin Hydrochloride |
| Dosage Form: | CAPSULE |
| Method: | ORAL |
| Original Marketing Date: | 02-11-2009 |
| Category Name: | ANDA |
| Application Number: | ANDA074823 |
| Labeler: | CARDINAL HEALTH |
| Substance Name: | TERAZOSIN HYDROCHLORIDE ANHYDROUS |
| Active Numerator Strength: | 5 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
| DEA Schedule: |